Search results
Leonard S. Schleifer (born 1953) is an American businessman and is the co-founder and chief executive of the biotechnology company Regeneron Pharmaceuticals.
3 days ago · About Leonard Schleifer. Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York company. Schleifer took Regeneron public in 1991; he owns nearly...
Leonard S. Schleifer, M.D., Ph.D., founded Regeneron in 1988, and has been a board member and the company’s president and chief executive officer since its inception. He currently serves as board co-Chair.
Leonard S. Schleifer, M.D., Ph.D., founded Regeneron in 1988, and has been a board member and the company’s president and chief executive officer since its inception. He currently serves as board co-chair.
Nov 30, 2021 · Following is the unofficial transcript of a CNBC interview with Regeneron Pharmaceuticals Co-Founder & CEO Dr. Leonard Schleifer on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Tuesday,...
Leonard S. Schleifer, M.D., Ph.D., has built and managed Regeneron since 1988, alongside his co-Founder George D. Yancopoulos, M.D., Ph.D. He is currently board co-Chair, president and chief executive officer of Regeneron.
CEO. The New York–based biotech Schleifer founded in 1988 has been much in the news this year for the drug, an antibody cocktail, it developed to fight COVID-19—and which was used in...
